{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T23:41:37Z","timestamp":1783294897085,"version":"3.54.6"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s13346-017-0453-9","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T19:15:32Z","timestamp":1512414932000},"page":"204-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Augmented bioavailability of felodipine through an \u03b1-linolenic acid-based microemulsion"],"prefix":"10.1007","volume":"8","author":[{"given":"Mahendra","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovita","family":"Kanoujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malti","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra B.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. R.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra K.","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhini A.","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"issue":"4","key":"453_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2165\/00003495-198836040-00002","volume":"36","author":"E Saltiel","year":"1988","unstructured":"Saltiel E, Ellrodt AG, Monk JP, Langley MS. Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs. 1988;36(4):387\u2013428. https:\/\/doi.org\/10.2165\/00003495-198836040-00002 .","journal-title":"Drugs"},{"issue":"2","key":"453_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1208\/s12249-009-9235-0","volume":"10","author":"PR Patil","year":"2009","unstructured":"Patil PR, Biradar SV, Paradkar AR. Extended release felodipine self-nanoemulsifying system. AAPS PharmSciTech. 2009;10(2):515\u201323. https:\/\/doi.org\/10.1208\/s12249-009-9235-0 .","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"453_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2125.1990.tb03600.x","volume":"29","author":"E Blychert","year":"1990","unstructured":"Blychert E, Wingstrand K, Edgar B, Lidman K. Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets. Br J Clin Pharmacol. 1990;29(1):39\u201345. https:\/\/doi.org\/10.1111\/j.1365-2125.1990.tb03600.x .","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"453_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejpb.2006.04.001","volume":"64","author":"EJ Kim","year":"2006","unstructured":"Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm. 2006;64(2):200\u20135. https:\/\/doi.org\/10.1016\/j.ejpb.2006.04.001 .","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"453_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijpharm.2009.06.001","volume":"379","author":"S Han","year":"2009","unstructured":"Han S, Yao T, Zhang X, Gan L, Zhu C, Yu H, et al. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation. Int J Pharm. 2009;379(1):18\u201324. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.06.001 .","journal-title":"Int J Pharm"},{"issue":"5","key":"453_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0928-0987(02)00051-9","volume":"15","author":"CM O'Driscoll","year":"2002","unstructured":"O'Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci. 2002;15(5):405\u201315. https:\/\/doi.org\/10.1016\/S0928-0987(02)00051-9 .","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"453_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","volume":"29","author":"CW Pouton","year":"2006","unstructured":"Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3):278\u201387. https:\/\/doi.org\/10.1016\/j.ejps.2006.04.016 .","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"453_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2008.03.021","volume":"129","author":"A Dahan","year":"2008","unstructured":"Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release. 2008;129(1):1\u201310. https:\/\/doi.org\/10.1016\/j.jconrel.2008.03.021 .","journal-title":"J Control Release"},{"issue":"5","key":"453_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cocis.2012.06.001","volume":"17","author":"M Fanun","year":"2012","unstructured":"Fanun M. Microemulsions as delivery systems. Curr Opin Colloid Interface Sci. 2012;17(5):306\u201313. https:\/\/doi.org\/10.1016\/j.cocis.2012.06.001 .","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"453_CR10","doi-asserted-by":"publisher","first-page":"195727","DOI":"10.5402\/2012\/195727","volume":"2012","author":"KT Savjani","year":"2012","unstructured":"Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:195727. https:\/\/doi.org\/10.5402\/2012\/195727 .","journal-title":"ISRN Pharm"},{"issue":"1","key":"453_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijpharm.2006.09.060","volume":"332","author":"AS Zidan","year":"2007","unstructured":"Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box Behnken design and desirability function. Int J Pharm. 2007;332(1):55\u201363. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.09.060 .","journal-title":"Int J Pharm"},{"issue":"1","key":"453_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijpharm.2009.12.055","volume":"388","author":"A Zvonar","year":"2010","unstructured":"Zvonar A, Berginc K, Kristl A. Ga\u00c5\u00a1perlin M. Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. Int J Pharm. 2010;388(1):151\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.12.055 .","journal-title":"Int J Pharm"},{"key":"453_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.colsurfb.2012.05.019","volume":"100","author":"S Bandyopadhyay","year":"2012","unstructured":"Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B: Biointerfaces. 2012;100:50\u201361. https:\/\/doi.org\/10.1016\/j.colsurfb.2012.05.019 .","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"81","key":"453_CR14","doi-asserted-by":"publisher","first-page":"77590","DOI":"10.1039\/C6RA15166C","volume":"6","author":"M Singh","year":"2016","unstructured":"Singh M, Kanoujia J, Singh P, Tripathi CB, Arya M, Parashar P, et al. Development of an \u03b1-linolenic acid containing soft nanocarrier for oral delivery: in vitro and in vivo evaluation. RSC Adv. 2016;6(81):77590\u2013602. https:\/\/doi.org\/10.1039\/C6RA15166C .","journal-title":"RSC Adv"},{"issue":"2","key":"453_CR15","first-page":"99","volume":"29","author":"SP Rathod","year":"1997","unstructured":"Rathod SP, Shah N, Balaraman R. Antihypertensive effect of dietary calcium and diltiazem, a calcium channel blocker on experimentally induced hypertensive rats. Indian J Pharmacol. 1997;29(2):99.","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"453_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s13318-013-0158-5","volume":"39","author":"BP Sahu","year":"2014","unstructured":"Sahu BP, Das MK. Preparation and in vitro\/in vivo evaluation of felodipine nanosuspension. Eur J Drug Metab Pharmacokinet. 2014;39(3):183\u201393. https:\/\/doi.org\/10.1007\/s13318-013-0158-5 .","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"453_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpharm.2007.08.057","volume":"345","author":"AS Narang","year":"2007","unstructured":"Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm. 2007;345(1):9\u201325. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.08.057 .","journal-title":"Int J Pharm"},{"issue":"6","key":"453_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","volume":"60","author":"CJH Porter","year":"2008","unstructured":"Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673\u201391. https:\/\/doi.org\/10.1016\/j.addr.2007.10.014 .","journal-title":"Adv Drug Deliv Rev"},{"issue":"16","key":"453_CR19","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","volume":"105","author":"R Marchioli","year":"2002","unstructured":"Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Circulation. 2002;105(16):1897\u2013903. https:\/\/doi.org\/10.1161\/01.CIR.0000014682.14181.F2 .","journal-title":"Circulation"},{"issue":"2","key":"453_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11883-003-0086-y","volume":"5","author":"C Schacky von","year":"2003","unstructured":"von Schacky C. The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep. 2003;5(2):139\u201345. https:\/\/doi.org\/10.1007\/s11883-003-0086-y .","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"453_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00395-007-0676-x","volume":"102","author":"C Pignier","year":"2007","unstructured":"Pignier C, Revenaz C, Rauly-Lestienne I, Cussac D, Delhon A, Gardette J, et al. Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current. Basic Res Cardiol. 2007;102(6):553\u201364. https:\/\/doi.org\/10.1007\/s00395-007-0676-x .","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"453_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjcard.2005.12.026","volume":"98","author":"JG Robinson","year":"2006","unstructured":"Robinson JG, Stone NJ. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol. 2006;98(4):39\u201349. https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.026 .","journal-title":"Am J Cardiol"},{"issue":"9","key":"453_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1440-1681.2006.04451.x","volume":"33","author":"TA Mori","year":"2006","unstructured":"Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol. 2006;33(9):842\u20136. https:\/\/doi.org\/10.1111\/j.1440-1681.2006.04451.x .","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"453_CR24","first-page":"24","volume":"11","author":"D Mozaffarian","year":"2005","unstructured":"Mozaffarian D. Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med. 2005;11(3):24\u201330; quiz 31, 79.","journal-title":"Altern Ther Health Med"},{"issue":"8","key":"453_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3109\/03639040903585143","volume":"36","author":"SK Singh","year":"2010","unstructured":"Singh SK, Prasad Verma PR, Razdan B. Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization. Drug Dev Ind Pharm. 2010;36(8):933\u201345. https:\/\/doi.org\/10.3109\/03639040903585143 .","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"453_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cocis.2010.10.001","volume":"16","author":"R Pal","year":"2011","unstructured":"Pal R. Rheology of simple and multiple emulsions. Curr Opin Colloid Interface Sci. 2011;16(1):41\u201360. https:\/\/doi.org\/10.1016\/j.cocis.2010.10.001 .","journal-title":"Curr Opin Colloid Interface Sci"},{"issue":"1","key":"453_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfa.2009.01.002","volume":"339","author":"JL Feng","year":"2009","unstructured":"Feng JL, Wang ZW, Zhang J, Wang ZN, Liu F. Study on food-grade vitamin E microemulsions based on nonionic emulsifiers. Colloids Surf A Physicochem Eng Asp. 2009;339(1):1\u20136. https:\/\/doi.org\/10.1016\/j.colsurfa.2009.01.002 .","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"5","key":"453_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cocis.2012.07.002","volume":"17","author":"DP Acharya","year":"2012","unstructured":"Acharya DP, Hartley PG. Progress in microemulsion characterization. Curr Opin Colloid Interface Sci. 2012;17(5):274\u201380. https:\/\/doi.org\/10.1016\/j.cocis.2012.07.002 .","journal-title":"Curr Opin Colloid Interface Sci"},{"issue":"1","key":"453_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","volume":"45","author":"MJ Lawrence","year":"2000","unstructured":"Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45(1):89\u2013121. https:\/\/doi.org\/10.1016\/S0169-409X(00)00103-4 .","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"453_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.colsurfa.2011.09.048","volume":"392","author":"S Gupta","year":"2011","unstructured":"Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Asp. 2011;392(1):145\u201355. https:\/\/doi.org\/10.1016\/j.colsurfa.2011.09.048 .","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"3","key":"453_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2009.01.018","volume":"135","author":"HY Nam","year":"2009","unstructured":"Nam HY, Kwon SM, Chung H, Lee SY, Kwon SH, Jeon H, et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2009;135(3):259\u201367. https:\/\/doi.org\/10.1016\/j.jconrel.2009.01.018 .","journal-title":"J Control Release"},{"issue":"1","key":"453_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijpharm.2014.05.031","volume":"471","author":"X You","year":"2014","unstructured":"You X, Xing Q, Tuo J, Song W, Zeng Y, Hu H. Optimizing surfactant content to improve oral bioavailability of ibuprofen in microemulsions: just enough or more than enough? Int J Pharm. 2014;471(1):276\u201384. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.05.031 .","journal-title":"Int J Pharm"},{"issue":"3","key":"453_CR33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/ajplegacy.1962.202.3.515","volume":"202","author":"HA Schroeder","year":"1962","unstructured":"Schroeder HA, Vinton WH. Hypertension induced in rats by small doses of cadmium. Am J Physiol Legacy Content. 1962;202(3):515\u20138.","journal-title":"Am J Physiol Legacy Content"},{"issue":"4","key":"453_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jps.2600630414","volume":"63","author":"JD Foulke","year":"1974","unstructured":"Foulke JD, Kessler WV, Born GS, Shaw SM, Vetter RJ. Effect of cadmium on sodium and potassium excretion and on action of hydrochlorothiazide in rats. J Pharm Sci. 1974;63(4):563\u20136. https:\/\/doi.org\/10.1002\/jps.2600630414 .","journal-title":"J Pharm Sci"},{"issue":"1","key":"453_CR35","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/1756-0500-7-931","volume":"7","author":"SK Mutiso","year":"2014","unstructured":"Mutiso SK, Rono DK, Bukachi F. Relationship between anthropometric measures and early electrocardiographic changes in obese rats. BMC Res Notes. 2014;7(1):931. https:\/\/doi.org\/10.1186\/1756-0500-7-931 .","journal-title":"BMC Res Notes"},{"issue":"4","key":"453_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ahj.2013.01.011","volume":"165","author":"A Nada","year":"2013","unstructured":"Nada A, Gintant GA, Kleiman R, Gutstein DE, Gottfridsson C, Michelson EL, et al. The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development. Am Heart J. 2013;165(4):489\u2013500. https:\/\/doi.org\/10.1016\/j.ahj.2013.01.011 .","journal-title":"Am Heart J"},{"issue":"11","key":"453_CR37","first-page":"566","volume":"48","author":"ZR Sermuksnien","year":"2012","unstructured":"Sermuksnien ZR, Kajenien A, Berskien K, Daunoravicien A, Kandratavicien SR. Assessment of the effect of anthropometric data on the alterations of cardiovascular parameters in Lithuanian elite male basketball players during physical load. Medicina. 2012;48(11):566\u201371.","journal-title":"Medicina"},{"issue":"3","key":"453_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0008-6363(01)00223-1","volume":"50","author":"P Taggart","year":"2001","unstructured":"Taggart P, Sutton PMI, Opthof T, Coronel R, Trimlett R, Pugsley W, et al. Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia. Cardiovasc Res. 2001;50(3):454\u201362. https:\/\/doi.org\/10.1016\/S0008-6363(01)00223-1 .","journal-title":"Cardiovasc Res"},{"issue":"5","key":"453_CR39","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.108.797035","volume":"119","author":"SS Chugh","year":"2009","unstructured":"Chugh SS, Reinier K, Singh T, Uy-Evanado A, Socoteanu C, Peters D, et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease. Circulation. 2009;119(5):663\u201370. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.797035 .","journal-title":"Circulation"},{"issue":"2","key":"453_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jacc.2005.08.067","volume":"47","author":"SMJM Straus","year":"2006","unstructured":"Straus SMJM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2005.08.067 .","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"453_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jelectrocard.2004.02.002","volume":"37","author":"N Watanabe","year":"2004","unstructured":"Watanabe N, Kobayashi Y, Tanno K, Miyoshi F, Asano T, Kawamura M, et al. Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol. 2004;37(3):191\u2013200. https:\/\/doi.org\/10.1016\/j.jelectrocard.2004.02.002 .","journal-title":"J Electrocardiol"},{"issue":"1","key":"453_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12012-007-0004-6","volume":"7","author":"WH Rowan","year":"2007","unstructured":"Rowan WH, Campen MJ, Wichers LB, Watkinson WP. Heart rate variability in rodents: uses and caveats in toxicological studies. Cardiovasc Toxicol. 2007;7(1):28\u201351. https:\/\/doi.org\/10.1007\/s12012-007-0004-6 .","journal-title":"Cardiovasc Toxicol"},{"key":"453_CR43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/oxfordjournals.eurheartj.a014868","volume":"17","author":"Task Force of The European Society of C","year":"1996","unstructured":"Task Force of The European Society of C. The North American Society of Pacing and Electrophysiology (Membership of the Task Force listed in the Appendix), Heart rate variability Standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17:354\u201381.","journal-title":"Eur Heart J"},{"issue":"9","key":"453_CR44","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0895-7061(95)00163-J","volume":"8","author":"SR Goldsmith","year":"1995","unstructured":"Goldsmith SR. Effect of amlodipine and felodipine on sympathetic activity and baroreflex function in normal humans. Am J Hypertens. 1995;8(9):902\u20138. https:\/\/doi.org\/10.1016\/0895-7061(95)00163-J .","journal-title":"Am J Hypertens"},{"issue":"2","key":"453_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.jhh.1000780","volume":"13","author":"MA James","year":"1999","unstructured":"James MA, Rakicka H, Panerai RB, Potter JF. Baroreflex sensitivity changes with calcium antagonist therapy in elderly subjects with isolated systolic hypertension. J Hum Hypertens. 1999;13(2):87\u201395. https:\/\/doi.org\/10.1038\/sj.jhh.1000780 .","journal-title":"J Hum Hypertens"},{"issue":"3","key":"453_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0008-6363(02)00275-4","volume":"54","author":"GR Ferrier","year":"2002","unstructured":"Ferrier GR, Redondo I, Zhu J, Murphy MG. Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes. Cardiovasc Res. 2002;54(3):601\u201310. https:\/\/doi.org\/10.1016\/S0008-6363(02)00275-4 .","journal-title":"Cardiovasc Res"},{"issue":"4","key":"453_CR47","first-page":"164","volume":"8","author":"CMC BP Ander","year":"2003","unstructured":"BP Ander CMC, Dupasquier MA, Prociuk GN. Pierce. Polyunsaturated fatty acids and their effects on cardiovascular disease. Exp Clin Cardiol. 2003;8(4):164\u201372.","journal-title":"Exp Clin Cardiol"},{"issue":"5","key":"453_CR48","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/ajcn\/48.5.1226","volume":"48","author":"JT Salonen","year":"1988","unstructured":"Salonen JT, Salonen R, Ihanainen M, Parviainen M, Sepp\u00e4nen R, Kantola M, et al. Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr. 1988;48(5):1226\u201332.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"453_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0828-282X(10)70455-4","volume":"26","author":"D Rodriguez-leyva","year":"2010","unstructured":"Rodriguez-leyva D, Bassett CMC, Mccullough R, Pierce GN. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alphalinolenic acid. Can J Cardiol. 2010;26(9):489\u201396. https:\/\/doi.org\/10.1016\/S0828-282X(10)70455-4 .","journal-title":"Can J Cardiol"},{"issue":"3","key":"453_CR50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-2275(20)31657-6","volume":"42","author":"EM Pound","year":"2001","unstructured":"Pound EM, Kang JX, Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res. 2001;42(3):346\u201351.","journal-title":"J Lipid Res"},{"issue":"2","key":"453_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0928-0987(02)00251-8","volume":"18","author":"E Merisko-Liversidge","year":"2003","unstructured":"Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18(2):113\u201320. https:\/\/doi.org\/10.1016\/S0928-0987(02)00251-8 .","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"453_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijpharm.2011.08.043","volume":"420","author":"L Hu","year":"2011","unstructured":"Hu L, Wu H, Niu F, Yan C, Yang X, Jia Y. Design of fenofibrate microemulsion for improved bioavailability. Int J Pharm. 2011;420(2):251\u20135. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.08.043 .","journal-title":"Int J Pharm"},{"issue":"2","key":"453_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejpb.2010.07.002","volume":"76","author":"G Sharma","year":"2010","unstructured":"Sharma G, Wilson K, Van der Walle CF, Sattar N, Petrie JR, Kumar MNVR. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm. 2010;76(2):159\u201369. https:\/\/doi.org\/10.1016\/j.ejpb.2010.07.002 .","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-017-0453-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T21:59:46Z","timestamp":1660082386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-017-0453-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s13346-017-0453-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]}}}